Updated

The Food and Drug Administration warned that GLP-1 drugs may pose a risk of a rare condition that causes vision loss, Ars Technica reported on November 10, 2026. The agency said the risk appears small and the data is mixed, but it wants patients to be aware. The warning concerns a rare condition and does not establish that the drugs cause it. The excerpt gives no case counts.